These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30656820)

  • 1. Risks of colorectal neoplasms and cardiovascular thromboembolic events after the combined use of selective COX-2 inhibitors and aspirin with 5-year follow-up: a meta-analysis.
    He P; Yang C; Ye G; Xie H; Zhong W
    Colorectal Dis; 2019 Apr; 21(4):417-426. PubMed ID: 30656820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.
    Yuan JQ; Yang M; Threapleton DE; Qi XS; Ye DQ; Mao C; Tang JL; Higgins JP
    Aliment Pharmacol Ther; 2016 Oct; 44(8):785-95. PubMed ID: 27534608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
    Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
    J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.
    Yang M; Wang HT; Zhao M; Meng WB; Ou JQ; He JH; Zou B; Lei PG
    Medicine (Baltimore); 2015 Oct; 94(40):e1592. PubMed ID: 26448006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
    Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
    BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
    Brusselaers N; Lagergren J
    BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
    Hur C; Simon LS; Gazelle GS
    Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis.
    Ma Y; You W; Cao Y; He X; Wang J; Zhang Y; Li J; Li J
    Chin Med J (Engl); 2023 Apr; 136(7):788-798. PubMed ID: 37027286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy of Aspirin in Preventing the Recurrence of Colorectal Adenoma: a Renewed Meta-Analysis of Randomized Trials.
    Zhao TY; Tu J; Wang Y; Cheng DW; Gao XK; Luo H; Yan BC; Xu XL; Zhang HL; Lu XJ; Wang YJ
    Asian Pac J Cancer Prev; 2016; 17(5):2711-7. PubMed ID: 27268656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials.
    Chen LC; Ashcroft DM
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):762-72. PubMed ID: 17457957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
    García Rodríguez LA; Barreales Tolosa L
    Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
    Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
    Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis].
    Jin XF; Tong JL; Ran ZH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1958-61. PubMed ID: 17923032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
    García Rodríguez LA; Martín-Pérez M; Hennekens CH; Rothwell PM; Lanas A
    PLoS One; 2016; 11(8):e0160046. PubMed ID: 27490468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs.
    Patrono C
    Curr Cardiol Rep; 2016 Mar; 18(3):25. PubMed ID: 26841787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint.
    Jankowski J; Hunt R
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1858-61. PubMed ID: 18708372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.